{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:14:29Z","timestamp":1788498869192,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Med"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40290-026-00624-y","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:31:38Z","timestamp":1784575898000},"page":"413-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Clinical Trial Participation on Quality of Life in Duchenne Muscular Dystrophy"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9384-6914","authenticated-orcid":false,"given":"Aidan W.","family":"Leffler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham J.","family":"Leffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle G.","family":"Contesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"4","key":"624_CR1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.22758","volume":"36","author":"CL Bladen","year":"2015","unstructured":"Bladen CL, Salgado D, Monges S, Foncuberta ME, Kekou K, Kosma K, et al. The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations. Hum Mutat. 2015;36(4):395\u2013402.","journal-title":"Hum Mutat"},{"issue":"10","key":"624_CR2","doi-asserted-by":"publisher","first-page":"18168","DOI":"10.3390\/molecules201018168","volume":"20","author":"MS Falzarano","year":"2015","unstructured":"Falzarano MS, Scotton C, Passarelli C, Ferlini A. Duchenne muscular dystrophy: from diagnosis to therapy. Molecules. 2015;20(10):18168\u201384.","journal-title":"Molecules"},{"issue":"14","key":"624_CR3","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1080\/09638288.2016.1196398","volume":"39","author":"YJ Lue","year":"2017","unstructured":"Lue YJ, Chen SS, Lu YM. Quality of life of patients with Duchenne muscular dystrophy: from adolescence to young men. Disabil Rehabil. 2017;39(14):1408\u201313.","journal-title":"Disabil Rehabil"},{"issue":"1","key":"624_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-018-1062-0","volume":"16","author":"L Uttley","year":"2018","unstructured":"Uttley L, Carlton J, Woods HB, Brazier J. A review of quality of life themes in Duchenne muscular dystrophy for patients and carers. Health Qual Life Outcomes. 2018;16(1):237.","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"624_CR5","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jacbts.2021.11.004","volume":"7","author":"TI Schultz","year":"2022","unstructured":"Schultz TI, Raucci FJ Jr, Salloum FN. Cardiovascular disease in Duchenne muscular dystrophy: overview and insight into novel therapeutic targets. JACC Basic Transl Sci. 2022;7(6):608\u201325. https:\/\/doi.org\/10.1016\/j.jacbts.2021.11.004.","journal-title":"JACC Basic Transl Sci"},{"key":"624_CR6","doi-asserted-by":"publisher","unstructured":"Yiu EM, Kornberg AJ. Duchenne muscular dystrophy. J Paediatr Child Health. 2015;51(8):759\u201364. https:\/\/doi.org\/10.1111\/jpc.12868?msockid=1f4fe38d96cf6d8730faf34b97756c2a.","DOI":"10.1111\/jpc.12868?msockid=1f4fe38d96cf6d8730faf34b97756c2a"},{"issue":"13","key":"624_CR7","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1080\/09638288.2016.1191552","volume":"39","author":"A Dany","year":"2017","unstructured":"Dany A, Rapin A, R\u00e9veill\u00e8re C, Calmus A, Tiffreau V, Morrone I, et al. Exploring quality of life in people with slowly-progressive neuromuscular disease. Disabil Rehabil. 2017;39(13):1262\u201370. https:\/\/doi.org\/10.1080\/09638288.2016.1191552.","journal-title":"Disabil Rehabil"},{"issue":"19","key":"624_CR8","doi-asserted-by":"publisher","first-page":"e2438","DOI":"10.1212\/WNL.0000000000011896","volume":"96","author":"PA Powell","year":"2021","unstructured":"Powell PA, Carlton J, Rowen D, Chandler F, Guglieri M, Brazier JE. Development of a new quality of life measure for Duchenne muscular dystrophy using mixed methods: the DMD-QoL. Neurology. 2021;96(19):e2438\u201350. https:\/\/doi.org\/10.1212\/WNL.0000000000011896.","journal-title":"Neurology"},{"issue":"1","key":"624_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/mus.23245","volume":"46","author":"TM Burns","year":"2012","unstructured":"Burns TM, Graham CD, Rose MR, Simmons Z. Quality of life and measures of quality of life in patients with neuromuscular disorders. Muscle Nerve. 2012;46(1):9\u201325. https:\/\/doi.org\/10.1002\/mus.23245.","journal-title":"Muscle Nerve"},{"issue":"1","key":"624_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12955-018-1062-0","volume":"16","author":"L Uttley","year":"2018","unstructured":"Uttley L, Carlton J, Woods HB, Brazier J. A review of quality of life themes in Duchenne muscular dystrophy for patients and carers. Health Qual Life Outcomes. 2018;16(1):237. https:\/\/doi.org\/10.1186\/s12955-018-1062-0.","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"624_CR11","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1007\/s11845-021-02915-6","volume":"191","author":"OM Fitzpatrick","year":"2022","unstructured":"Fitzpatrick OM, Murphy C, Duignan E, Egan K, Hennessy BT, Grogan L, et al. The cost of cancer care: how far would you go for a trial? Ir J Med Sci. 2022;191(6):2487\u201391. https:\/\/doi.org\/10.1007\/s11845-021-02915-6.","journal-title":"Ir J Med Sci"},{"issue":"6","key":"624_CR12","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.jpainsymman.2013.07.004","volume":"47","author":"AC Enzinger","year":"2014","unstructured":"Enzinger AC, Zhang B, Weeks JC, Prigerson HG. Clinical trial participation as part of end-of-life cancer care: associations with medical care and quality of life near death. J Pain Symptom Manage. 2014;47(6):1078\u201390. https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.07.004.","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"624_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03209-7","volume":"19","author":"NL Crossnohere","year":"2024","unstructured":"Crossnohere NL, Campoamor NB, Camino E, Dresnick E, Martschenko DO, Rodrigues V, et al. Barriers to diverse clinical trial participation in Duchenne muscular dystrophy: engaging Hispanic\/Latina caregivers and health professionals. Orphanet J Rare Dis. 2024;19(1):207. https:\/\/doi.org\/10.1186\/s13023-024-03209-7.","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"624_CR14","doi-asserted-by":"publisher","first-page":"e1320","DOI":"10.1200\/OP.21.00789","volume":"18","author":"S Sidana","year":"2022","unstructured":"Sidana S, Allmer C, Larson MC, Dueck A, Yost K, Warsame R, et al. Patient experience in clinical trials: quality of life, financial burden, and perception of care in patients with multiple myeloma or lymphoma enrolled on clinical trials compared with standard care. JCO Oncol Pract. 2022;18(8):e1320\u201333. https:\/\/doi.org\/10.1200\/OP.21.00789.","journal-title":"JCO Oncol Pract"},{"issue":"11","key":"624_CR15","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.nmd.2023.10.011","volume":"33","author":"S Geuens","year":"2023","unstructured":"Geuens S, Willen J, Antonis C, Stegen G, Gielis E, Cuveele E, et al. The impact of clinical trial participation on quality of life and psychosocial well-being in children with Duchenne muscular dystrophy and their parents. Neuromuscul Disord. 2023;33(11):877\u201381. https:\/\/doi.org\/10.1016\/j.nmd.2023.10.011.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"624_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/ojped.2012.21001","volume":"2","author":"F Wulf","year":"2012","unstructured":"Wulf F, Krasuska M, Bullinger M. Determinants of decision-making and patient participation in paediatric clinical trials: a literature review. Open J Pediatr. 2012;2(1):1\u201317. https:\/\/doi.org\/10.4236\/ojped.2012.21001.","journal-title":"Open J Pediatr"},{"issue":"1","key":"624_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1069-6","volume":"14","author":"RS Paquin","year":"2019","unstructured":"Paquin RS, Fischer R, Mansfield C, Mange B, Beaverson K, Ganot A, et al. Priorities when deciding on participation in early-phase gene therapy trials for Duchenne muscular dystrophy: a best-worst scaling experiment in caregivers and adult patients. Orphanet J Rare Dis. 2019;14(1):102. https:\/\/doi.org\/10.1186\/s13023-019-1069-6.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"624_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-024-02698-8","volume":"13","author":"V Bencheva","year":"2024","unstructured":"Bencheva V, Mann NK, Rombey T, Pieper D, Schmiedl S. Barriers and facilitators to enrollment in pediatric clinical trials: an overview of systematic reviews. Syst Rev. 2024;13(1):283. https:\/\/doi.org\/10.1186\/s13643-024-02698-8.","journal-title":"Syst Rev"},{"issue":"7","key":"624_CR19","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1177\/0883073815627879","volume":"31","author":"Y Wei","year":"2016","unstructured":"Wei Y, Speechley KN, Zou G, Campbell C. Factors associated with health-related quality of life in children with Duchenne muscular dystrophy. J Child Neurol. 2016;31(7):879\u201386. https:\/\/doi.org\/10.1177\/0883073815627879.","journal-title":"J Child Neurol"},{"issue":"1","key":"624_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/2168479018764650","volume":"53","author":"T Franson","year":"2019","unstructured":"Franson T, Kinnett K, Cripe TP. Unique burdens of pediatric clinical trials in Duchenne muscular dystrophy, April 20\u201321, 2017, Bethesda, Maryland, USA. Ther Innov Regul Sci. 2019;53(1):154\u201363. https:\/\/doi.org\/10.1177\/2168479018764650.","journal-title":"Ther Innov Regul Sci"},{"key":"624_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cct.2015.11.006","volume":"46","author":"HL Peay","year":"2016","unstructured":"Peay HL, Scharff H, Tibben A, Wilfond B, Bowie J, Johnson J, et al. \u201cWatching time tick by\u2026\u201d: decision making for Duchenne muscular dystrophy trials. Contemp Clin Trials. 2016;46:1\u20136. https:\/\/doi.org\/10.1016\/j.cct.2015.11.006.","journal-title":"Contemp Clin Trials"},{"issue":"4","key":"624_CR22","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/09658211.2015.1023809","volume":"24","author":"P B\u0105bel","year":"2015","unstructured":"B\u0105bel P. Memory of pain induced by physical exercise. Memory. 2015;24(4):548\u201359. https:\/\/doi.org\/10.1080\/09658211.2015.1023809.","journal-title":"Memory"},{"issue":"4","key":"624_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1006\/jesp.1997.1333","volume":"33","author":"TR Mitchell","year":"1997","unstructured":"Mitchell TR, Thompson L, Peterson E, Cronk R. Temporal adjustments in the evaluation of events: the \u201crosy view.\u201d J Exp Soc Psychol. 1997;33(4):421\u201348. https:\/\/doi.org\/10.1006\/jesp.1997.1333.","journal-title":"J Exp Soc Psychol"},{"key":"624_CR24","unstructured":"Johns Hopkins\u2014Clinical trial research: why take part? 2025 [cited 2025 Oct 18]. https:\/\/www.hopkinsmedicine.org\/research\/understanding-clinical-trials\/why-take-part."},{"key":"624_CR25","unstructured":"National Institute of Mental Health. Clinical research trials and you: questions and answers (NIH Publication No. 23-MH-4379). U.S. Department of Health and Human Services, National Institutes of Health; 2023. https:\/\/www.nimh.nih.gov\/health\/publications\/clinical-research-trials-and-you-questions-and-answers. Accessed 17 June 2026"}],"container-title":["Pharmaceutical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-026-00624-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40290-026-00624-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-026-00624-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:22:55Z","timestamp":1788495775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40290-026-00624-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["624"],"URL":"https:\/\/doi.org\/10.1007\/s40290-026-00624-y","relation":{},"ISSN":["1178-2595","1179-1993"],"issn-type":[{"value":"1178-2595","type":"print"},{"value":"1179-1993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"23 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to privacy concerns, qualitative data from interviews cannot be shared publicly but can be made available upon reasonable request from the corresponding author.","order":2,"name":"Ethics","label":"Availability of data and material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Aidan Leffler designed the study, conducted and coded interviews, analyzed results, and wrote the manuscript in collaboration with Graham Leffler. Graham Leffler conducted and coded interviews, analyzed results, and wrote the manuscript in collaboration with Aidan Leffler. Marielle Contesse consulted on study design, completed statistical analyses, and reviewed and edited the manuscript.","order":3,"name":"Ethics","label":"Author contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the 1964 Declaration of Helsinki and its later amendments, with the exception that this study was not registered on a trials database. Ethics committee approval was granted by the University of Washington Institutional Review Board, Human Subjects Division.","order":4,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study (see online resource 2). The authors affirm that the human research participants provided informed consent for the interview quotes included in the manuscript.","order":5,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":7,"name":"Ethics","label":"Code for availability","group":{"name":"EthicsHeading","label":"Declarations"}}]}}